21163 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA; Animal cells Tumor cells
Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines
#302Method for determining the anti-tumor efficacy of monoclonal antibodies
#303Directly injectable formulations which provide enhanced cryoprotection of cell products
#304ANTI-TUMORAL CELLS
#305Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer
#306Immunogen platform
#307TRIMODAL CANCER THERAPY
#308Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy
#309TAPASIN AUGMENTATION FOR ENHANCED IMMUNE RESPONSE
#310Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
#311Cell expressing complexes of IL-15 and IL-15Ralpha
#312IMMUNOGENIC TREATMENT OF CANCER BY PEPTIDES INDUCING THE PLASMA MEMBRANE EXPOSURE OF ERP57
#313CHEMOKINE GENE-MODIFIED CELLS FOR CANCER IMMUNOTHERAPY
#314Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof
#315PROSPECTIVE IDENTIFICATION AND CHARACTERIZATION OF BREAST CANCER STEM CELLS
#316Inhibitors of LL-37 Mediated Immune Reactivity to Self Nucleic Acids
#317Preparation of vaccines using photosensitizer and light
#318Increased T-cell tumor infiltration and eradication of metastases by mutant light
#319VACCINES USING NUCLEIC ACID-LIPID COMPLEXES
#320Methods for cancer treatment using stem cells
#321VACCINE COMPOSITIONS
#322Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof
#323Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine
#324CD40 ligand-enhanced cells and methods of modulating an immune response to an antigen
#325STAT3 ANTAGONISTS AND THEIR USES AS VACCINES AGAINST CANCER
#326Lectin compositions and methods for modulating an immune response to an antigen
#327PD-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof
#328Apparatus, system, and method for creating immunologically enhanced spaces in-vivo
#329CHEMOTHERAPEUTIC AGENTS AS ANTI-CANCER VACCINE ADJUVANTS AND THERAPEUTIC METHODS THEREOF
#330Enhancement of immune responses by 4-1BB-binding agents
#331Complexes Derived from Heterohybrid Cells and Uses Thereof
#332TUMOR/B-CELL HYBRID CELLS AND USES THEREOF
#333IN VIVO CELL SURFACE ENGINEERING
#334Extracellular matrix cancer vaccine adjuvant
#335Methods and compositions using for enhancing immunogenicity by prime boost
#336Canine tumor cell and allogeneic dendritic cell fused vaccine and method for preparing the same
#337MIXED HAPTENIZED TUMOR CELLS AND EXTRACTS AND METHODS OF TREATING OR SCREENING FOR CANCER
#338Method for treating stage IV melanoma
#339Method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response
#340METHODS AND MATERIALS FOR MAKING AND USING VACCINES
#341BINDING DOMAIN-IMMUNOGLOBULIN FUSION PROTEINS
#342Methods of treating tumors in immune-privileged sites
#343Tumor immunity
#344Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods
#345Tumor-initiating cells and methods of use
#346Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates
#347Immunostimulatory compositions and methods
#348Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer
#349Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
#350MODEL MEMBRANE SYSTEMS
#351Light-mediated anti-cell proliferative compositions and methods
#352TUMOR VACCINE
#353Photodynamic therapy-generated mesothelioma vaccine
#354METHODS FOR TREATING MICA-RELATED DISORDERS
#355Anti-Notch3 agonist antibodies and their use in the treatment of Notch3-related diseases
#356METHOD FOR PRODUCING A VACCINE FOR THE TREATMENT OF CANCER
#357Th1 vaccination priming for active immunotherapy
#358Tumour vaccine comprising allogenic or xenogeneic tumour cells
#359Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization
#360Hybrid cells for treating cancer patients
#361Binding domain-immunoglobulin fusion proteins
#362Processes for treating subjects carrying viral infectious agent
#363Induction of immune responses to isoaspartyl-modified antigens
#364COMPOSITION AND METHOD FOR TREATING ESOPHAGEAL DYSPLASIA
#365Combinatorial Therapy of Cancer and Infectious Diseases with Anti-B7-H1 Antibodies
#366Tumor cell-based cancer immunotherapeutic compositions and methods
#367Artificial lymph node for treating cancer
#368Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
#369Compositions and methods for inducing tumor resistance
#370Defective ribosomal products in blebs (DRibbles) and methods of use to stimulate an immune response
#371Metastasis inhibition preparations and methods
#372IMMUNOGEN PLATFORM
#373Antibodies and related molecules that bind to 24P4C12 proteins
#374VACCINES USING NUCLEIC ACID-LIPID COMPLEXES
#375Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells
#376Tumor vaccine
#377METHOD FOR TREATING TUMOR USING IRRADIATED TUMOR CELL EXPRESSING HUMAN HEPATITIS B SURFACE ANTIGEN AND A PHARMACEUTICAL COMPOSITION COMPRISING THE TUMOR CELL
#378Renal carcinoma cell line and uses thereof
#379Compositions containing LAG-3 and cells that secrete GM-CSF and methods of use
#380Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours
#381Increased T-cell tumor infiltration and eradication of metastases by mutant light
#382Combination therapy of hybrid cells with BCG injection for treating Cancer Patients
#383Immunostimulatory Combinations for Vaccine Adjuvants
#384Bioactive molecular matrix and methods of use in the treatment of disease
#385Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response
#386Human prostate cell lines in cancer treatment
#387KIT FOR TREATING A HEALTH CONDITION BY INDUCING TRANSLOCATION OF A CALRETICULIN PROTEIN TO A CELLULAR MEMBRANE
#388Expression of class II transactivator fusion proteins for control of tumor growth
#389PD-1 ANTIBODIES IN COMBINATION WITH A CYTOKINE-SECRETING CELL AND METHODS OF USE THEREOF
#390PHARMACEUTICAL COMPOUND FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT OR ERP57 TRANSLOCATION
#391Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
#392SERVICE FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT TRANSLOCATION
#393METHOD, APPARATUS, AND COMPOUND FOR EFFECTING LOCALIZED, NON-SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER
#394Prospective identification and characterization of breast cancer stem cells
#395Methods for Discovering Antibodies Specific to Cancer Cells and Antibodies Discovered Thereby
#396Dendritic cells loaded with heat shocked melanoma cell bodies
#397Synergistic Effect of Tgf-Beta Blockade and Immunogenic Agents on Tumors
#398Methods of using B7-DC molecules to induce or enhance an immune response
#399Prostate stem cell
#400Dendritic cell co-stimulatory molecules
#401Treating Tumors Using Implants Comprising Combinations of Allogeneic Cells
#402Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines
#403Method for enhancing T cell response
#404Method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response
#405CELL COMPOSITION AND METHOD FOR TREATING CANCER
#406Determining the capability of a test compound to affect solid tumor stem cells
#407Tumor cell vaccines
#408Tissue vaccines and uses thereof
#409Anti-Notch3 antibodies
#410Anti-Notch3 agonist antibodies and their use in the treatment of Notch3-related diseases
#411Ablative immunotherapy
#412Dendritic Cells Loaded with Heat Shocked Melanoma Cell Bodies
#413Dendritic Cells Loaded with Heat Shocked Melanoma Cell Bodies
#414Vaccination with immuno-isolated cells producing an immunomodulator
#415Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine
#416Method for increasing tumor cell immunogenicity using heat shock protein
#417Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
#418Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer
#419MODEL MEMBRANE SYSTEMS
#420Cancer immunotherapy compositions and methods of use
#421Compositions and Methods for Inducing Anti-Tumor Immunity
#422Genetically modified cells expressing a TGF beta inhibitor, the cells being lung cancer cells
#423Isolation and use of solid tumor stem cells
#424Therapeutic Compositions and Vaccines By Glycosyl-Phosphatidylinositol (Gpi)-Anchored Cytokines and Immunostimulatory Molecules
#425Immunological Methods of Treating Cancer
#426Method for treating cancer using a Notch4 ligand antagonist
#427Isolation and use of solid tumor stem cells
#428Preparation of Vaccines Using Photosensitizers and Light
#429Hybrid cells
#430Immunomodulating compositions and uses therefor
#431Methods for targeting solid tumor stem cells in a solid tumor using a notch4 receptor antagonist
#432Immunostimulatory compositions and methods
#433In vivo cell surface engineering
#434Tumor-derived biological antigen presenting particles
#435Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine
#436Cell fusions and methods of making and using the same
#437Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins
#438Preparation of vaccines using a photosensitizer and light
#439Method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response
#440ANTITUMOR VACCINATION USING ALLOGENEIC TUMOR CELLS EXPRESSING ALPHA (1,3)-GALACTOSYLTRANSFERASE
#441Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyl transferase
#442Nucleic acid encoding dendritic cell co-stimulatory molecules
#443Directly injectable formulations which provide enhanced cryoprotection of cell products
#444Method for producing a vaccine for the treatment of cancer
#445Cells used as carriers for bacteria
#446Rapid one-step generation of antigen loaded dendritic cell vaccine from precursors
#447Tumor specific monoclonal antibodies
#448Methods of using nucleic acid vector-lipid complexes
#449Genetically modified tumor cells as cancer vaccines
#450Dendritic cells loaded with heat shocked melanoma cell bodies
#451Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds
#452Compositions and methods for WT1 specific immunotherapy
#453Tumor cells with increased immunogenicity and uses therfor
#454Flagellin-based adjuvants and vaccines
#455Isolation and use of solid tumor stem cells
#456Process of cell electrofusion
#457Immortalized natural killer cell line
#458Fiber-modified adenoviral vectors for enhanced transduction of tumor cells
#459Cytokine-expressing cellular vaccines for treatment of prostate cancer
#460Methods and compositions for the targeting of a systemic immune response to specific organs or tissues
#461Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof
#462Isolation and use of solid tumor stem cells
#463Method for tumor treatment using infusion of xenogeneic cells to induce hyperacute rejection and innocent bystander effect
#464Vaccination with immuno-isolated cells producing an immunomodulator
#465Novel therapeutic processes for treating infectious agents using same epitope specific antigens, and useful compositions therefor
#466Breast cancer cell lines and uses thereof
#467Novel therapeutic processes for treating cancer with trained or adopted immune cells, and useful compositions therefor
#468Novel therapeutic processes for treating cancer with specific antigens
#469Novel therapeutic processes for treating infectious agents by training or adoptive transfer of immune cells, and useful compositions therefor
#470Novel therapeutic processes for enhancing immunized states of vaccinated subjects
#471Use of human prostate cell lines in cancer treatment
#472Superantigen enhancement of specific immune responses
#473Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer
#474Low dose haptenized tumor cell and tumor cell extract immunotherapy
#475Adjuvant preparation for the induction of specific immunity
#476Novel complexes for inducing an immune response
#477Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
#478Tumor/B-cell hybrid cells and uses thereof
#479Cell targeting compositions and methods of using the same
#480Compositions for eliciting immune response and methods for using same
#481Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
#482Cell fusions and methods of making and using the same
#483Methods for producing functional antigen presenting dendritic cells using biodegradable microparticles for delivery of antigenic materials
#484Hybrid cells
#485Method for immune response eliciting in a mammal
#486Therapeutic processes and useful compositions therefor
#487Cells expressing anti-Fc receptor binding components
#488Novel therapeutic vaccination processes, and useful compositions therefor
#489Cellular vaccines and immunotherapeutics and methods for their preparation
#490Novel therapeutic processes for establishing or enhancing an immunized state, and compositions useful therefor
#491Cellular vaccines comprising adjuvants
#492Lectin compositions and methods for modulating an immune response to an antigen
#493Compositions and methods for selected tumour treatment
#494Human prostate cell lines in cancer treatment
#495Non-linear amplitude dielectrophoresis waveform for cell fusion
#496Immune activation by double-stranded polynucleotides
#497Allogenic vaccine that contains a costimulatory polypeptide-expresing tumor cell
#498Increased T-cell tumor infiltration by mutant LIGHT
#499Human prostate cell lines in cancer treatment
#500Enhancement of immune responses by 4-1bb-binding agents
#501Antigen presenting cells, method for their preparation and their use for cancer vaccines
#502Tumor cell vaccines
#503Multifunctional linker technology containing an N4 group